Beijing GoBroad Boren Hospital

Beijing GoBroad Boren Hospital is a leading specialty hospital under the GoBroad Healthcare Group focused on complex hematological diseases—including leukemias and lymphomas—solid tumors such as liver cancer and brain/neurodegenerative disorders like Parkinson’s disease. The institution integrates high-level clinical care with translational biomedical research—especially excelling at innovative immunotherapies such as autologous/universal/allogenic CART treatments targeting antigens like BCMA/CD19/CD33/CD5/CD7—and has performed thousands of successful adult/pediatric stem cell transplants at internationally competitive standards. Its medical team includes renowned specialists with decades-long expertise who have published widely cited work in the field. The hospital rapidly incorporates newly approved targeted drugs into practice—for example being first to offer taletrectinib post-NMPA approval—and maintains collaborations/advisory relationships with global leaders such as Mayo Clinic International and MD Anderson Cancer Center.